These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 31615730)
1. DNA repair inhibitors to enhance radiotherapy: Progresses and limitations. Ferreira S; Dutreix M Cancer Radiother; 2019 Dec; 23(8):883-890. PubMed ID: 31615730 [TBL] [Abstract][Full Text] [Related]
2. [Biomarkers of radiation-induced DNA repair processes]. Vallard A; Rancoule C; Guy JB; Espenel S; Sauvaigo S; Rodriguez-Lafrasse C; Magné N Bull Cancer; 2017 Nov; 104(11):981-987. PubMed ID: 29132682 [TBL] [Abstract][Full Text] [Related]
3. Phosphatidylinositol 3-kinase/Akt signaling as a key mediator of tumor cell responsiveness to radiation. Toulany M; Rodemann HP Semin Cancer Biol; 2015 Dec; 35():180-90. PubMed ID: 26192967 [TBL] [Abstract][Full Text] [Related]
4. miR-21-mediated Radioresistance Occurs via Promoting Repair of DNA Double Strand Breaks. Hu B; Wang X; Hu S; Ying X; Wang P; Zhang X; Wang J; Wang H; Wang Y J Biol Chem; 2017 Feb; 292(8):3531-3540. PubMed ID: 28096467 [TBL] [Abstract][Full Text] [Related]
5. Inhibitors of DNA double-strand break repair at the crossroads of cancer therapy and genome editing. Ray U; Raghavan SC Biochem Pharmacol; 2020 Dec; 182():114195. PubMed ID: 32798465 [TBL] [Abstract][Full Text] [Related]
6. DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer. Huang RX; Zhou PK Signal Transduct Target Ther; 2020 May; 5(1):60. PubMed ID: 32355263 [TBL] [Abstract][Full Text] [Related]
7. Targeting DNA Double-Strand Break Repair Pathways to Improve Radiotherapy Response. Toulany M Genes (Basel); 2019 Jan; 10(1):. PubMed ID: 30621219 [TBL] [Abstract][Full Text] [Related]
8. Diosmetin enhances the sensitivity of radiotherapy by suppressing homologous recombination in endometrial cancer. Hu Z; Cai B; Wang M; Wen X; Geng A; Hu X; Xue R; Mao Z; Jiang Y; Wan X Cell Cycle; 2020 Nov; 19(22):3115-3126. PubMed ID: 33064975 [TBL] [Abstract][Full Text] [Related]
9. Targeting DNA double strand break repair with hyperthermia and DNA-PKcs inhibition to enhance the effect of radiation treatment. van Oorschot B; Granata G; Di Franco S; Ten Cate R; Rodermond HM; Todaro M; Medema JP; Franken NA Oncotarget; 2016 Oct; 7(40):65504-65513. PubMed ID: 27602767 [TBL] [Abstract][Full Text] [Related]
10. Targeting base excision repair as a sensitization strategy in radiotherapy. Vens C; Begg AC Semin Radiat Oncol; 2010 Oct; 20(4):241-9. PubMed ID: 20832016 [TBL] [Abstract][Full Text] [Related]
11. Cyclin D1 silencing suppresses tumorigenicity, impairs DNA double strand break repair and thus radiosensitizes androgen-independent prostate cancer cells to DNA damage. Marampon F; Gravina G; Ju X; Vetuschi A; Sferra R; Casimiro M; Pompili S; Festuccia C; Colapietro A; Gaudio E; Di Cesare E; Tombolini V; Pestell RG Oncotarget; 2016 Feb; 7(5):5383-400. PubMed ID: 26689991 [TBL] [Abstract][Full Text] [Related]
12. The relative biological effectiveness of proton irradiation in dependence of DNA damage repair. Deycmar S; Faccin E; Kazimova T; Knobel PA; Telarovic I; Tschanz F; Waller V; Winkler R; Yong C; Zingariello D; Pruschy M Br J Radiol; 2020 Mar; 93(1107):20190494. PubMed ID: 31687835 [TBL] [Abstract][Full Text] [Related]
13. DNA Double Strand Breaks Repair Inhibitors: Relevance as Potential New Anticancer Therapeutics. Kopa P; Macieja A; Galita G; Witczak ZJ; Poplawski T Curr Med Chem; 2019; 26(8):1483-1493. PubMed ID: 29446719 [TBL] [Abstract][Full Text] [Related]
14. Genistein sensitizes glioblastoma cells to carbon ions via inhibiting DNA-PKcs phosphorylation and subsequently repressing NHEJ and delaying HR repair pathways. Liu X; Li P; Hirayama R; Niu Y; Liu X; Chen W; Jin X; Zhang P; Ye F; Zhao T; Liu B; Li Q Radiother Oncol; 2018 Oct; 129(1):84-94. PubMed ID: 29685705 [TBL] [Abstract][Full Text] [Related]
15. Genetic variations in DNA repair genes, radiosensitivity to cancer and susceptibility to acute tissue reactions in radiotherapy-treated cancer patients. Chistiakov DA; Voronova NV; Chistiakov PA Acta Oncol; 2008; 47(5):809-24. PubMed ID: 18568480 [TBL] [Abstract][Full Text] [Related]
16. DDB2 increases radioresistance of NSCLC cells by enhancing DNA damage responses. Zou N; Xie G; Cui T; Srivastava AK; Qu M; Yang L; Wei S; Zheng Y; Wang QE Tumour Biol; 2016 Oct; 37(10):14183-14191. PubMed ID: 27553023 [TBL] [Abstract][Full Text] [Related]
17. Inhibiting DNA-PKcs in a non-homologous end-joining pathway in response to DNA double-strand breaks. Dong J; Zhang T; Ren Y; Wang Z; Ling CC; He F; Li GC; Wang C; Wen B Oncotarget; 2017 Apr; 8(14):22662-22673. PubMed ID: 28186989 [TBL] [Abstract][Full Text] [Related]
18. Cooperative effect of BI-69A11 and celecoxib enhances radiosensitization by modulating DNA damage repair in colon carcinoma. Pal I; Dey KK; Chaurasia M; Parida S; Das S; Rajesh Y; Sharma K; Chowdhury T; Mandal M Tumour Biol; 2016 May; 37(5):6389-402. PubMed ID: 26631035 [TBL] [Abstract][Full Text] [Related]
19. The purine scaffold Hsp90 inhibitor PU-H71 sensitizes cancer cells to heavy ion radiation by inhibiting DNA repair by homologous recombination and non-homologous end joining. Lee Y; Li HK; Masaoka A; Sunada S; Hirakawa H; Fujimori A; Nickoloff JA; Okayasu R Radiother Oncol; 2016 Oct; 121(1):162-168. PubMed ID: 27666928 [TBL] [Abstract][Full Text] [Related]
20. DNA as the main target in radiotherapy-a historical overview from first isolation to anti-tumour immune response. Frey B; Borgmann K; Jost T; Greve B; Oertel M; Micke O; Eckert F Strahlenther Onkol; 2023 Dec; 199(12):1080-1090. PubMed ID: 37620671 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]